Skip to main content
Journal cover image

Extracellular adenosine signaling in bone health and disease.

Publication ,  Journal Article
Newman, H; Varghese, S
Published in: Curr Opin Pharmacol
June 2023

Purinergic signaling is a key molecular pathway in the maintenance of bone health and regeneration. P1 receptor signaling, which is activated by extracellular adenosine, has emerged as a key metabolic pathway that regulates bone tissue formation, function, and homeostasis. Extracellular adenosine is mainly produced by ectonucleotidases, and alterations in the function of these enzymes or compromised adenosine generation can result in bone disorders, such as osteoporosis and impaired fracture healing. This mini review discusses the key role played by adenosine in bone health and how its alterations contribute to bone diseases, as well as potential therapeutic applications of exogenous adenosine to combat bone diseases like osteoporosis and injury.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Curr Opin Pharmacol

DOI

EISSN

1471-4973

Publication Date

June 2023

Volume

70

Start / End Page

102378

Location

England

Related Subject Headings

  • Pharmacology & Pharmacy
  • Osteoporosis
  • Humans
  • Bone and Bones
  • Bone Diseases
  • Bone Density
  • Adenosine Triphosphate
  • Adenosine
  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Newman, H., & Varghese, S. (2023). Extracellular adenosine signaling in bone health and disease. Curr Opin Pharmacol, 70, 102378. https://doi.org/10.1016/j.coph.2023.102378
Newman, Hunter, and Shyni Varghese. “Extracellular adenosine signaling in bone health and disease.Curr Opin Pharmacol 70 (June 2023): 102378. https://doi.org/10.1016/j.coph.2023.102378.
Newman H, Varghese S. Extracellular adenosine signaling in bone health and disease. Curr Opin Pharmacol. 2023 Jun;70:102378.
Newman, Hunter, and Shyni Varghese. “Extracellular adenosine signaling in bone health and disease.Curr Opin Pharmacol, vol. 70, June 2023, p. 102378. Pubmed, doi:10.1016/j.coph.2023.102378.
Newman H, Varghese S. Extracellular adenosine signaling in bone health and disease. Curr Opin Pharmacol. 2023 Jun;70:102378.
Journal cover image

Published In

Curr Opin Pharmacol

DOI

EISSN

1471-4973

Publication Date

June 2023

Volume

70

Start / End Page

102378

Location

England

Related Subject Headings

  • Pharmacology & Pharmacy
  • Osteoporosis
  • Humans
  • Bone and Bones
  • Bone Diseases
  • Bone Density
  • Adenosine Triphosphate
  • Adenosine
  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences